{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:09:17Z","timestamp":1794870557694,"version":"4.9.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022M3A9G1014520"],"award-info":[{"award-number":["2022M3A9G1014520"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2023R1A2C2003034"],"award-info":[{"award-number":["2023R1A2C2003034"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019M3D1A1078938"],"award-info":[{"award-number":["2019M3D1A1078938"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijbiomac.2026.151905","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T07:32:06Z","timestamp":1775633526000},"page":"151905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["NIM5 series brain-penetrant NLRP3 inflammasome inhibitors suppress neuroinflammation in EAE and Alzheimer's models"],"prefix":"10.1016","volume":"361","author":[{"given":"Muhammad","family":"Haseeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uisuk","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangdun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151905_bb0005","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016287","article-title":"Inflammasomes","volume":"6","author":"de Zoete","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151905_bb0010","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.it.2019.09.005","article-title":"Emerging activators and regulators of inflammasomes and pyroptosis","volume":"40","author":"Xue","year":"2019","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151905_bb0015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"issue":"50","key":"10.1016\/j.ijbiomac.2026.151905_bb0020","doi-asserted-by":"crossref","first-page":"41732","DOI":"10.1074\/jbc.M112.381228","article-title":"Multiple binding sites on the pyrin domain of ASC protein allow self-association and interaction with NLRP3 protein","volume":"287","author":"Vajjhala","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151905_bb0025","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151905_bb0030","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/cdd.2013.37","article-title":"AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC","volume":"20","author":"Sagulenko","year":"2013","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151905_bb0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41419-020-2565-2","article-title":"Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype","volume":"11","author":"Hou","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151905_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s44400-025-00011-5","article-title":"Post-symptomatic NLRP3 inhibition rescues cognitive impairment and mitigates amyloid and tau driven neurodegeneration, npj","volume":"1","author":"Auger","year":"2025","journal-title":"Dementia"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2026.151905_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-510X(02)00030-8","article-title":"Caspase-1 expression in multiple sclerosis plaques and cultured glial cells","volume":"197","author":"Ming","year":"2002","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151905_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuron.2006.09.011","article-title":"The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration","volume":"52","author":"Hauser","year":"2006","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151905_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41232-018-0085-6","article-title":"Amyloid \u03b2 directly interacts with NLRP3 to initiate inflammasome activation: identification of an intrinsic NLRP3 ligand in a cell-free system","volume":"38","author":"Nakanishi","year":"2018","journal-title":"Inflammation and Regeneration"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151905_bb0060","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbi.2007.10.001","article-title":"Interleukin-18 produced by peripheral blood cells is increased in Alzheimer\u2019s disease and correlates with cognitive impairment","volume":"22","author":"Bossu","year":"2008","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151905_bb0065","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41573-022-00477-5","article-title":"Thinking outside the box: non-canonical targets in multiple sclerosis","volume":"21","author":"Bierhansl","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.151905_bb0070","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","article-title":"Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management","volume":"367","author":"Singh","year":"2024","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151905_bb0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s13311-012-0172-3","article-title":"Role of immunosuppressive therapy for the treatment of multiple sclerosis","volume":"10","author":"Stankiewicz","year":"2013","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151905_bb0080","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/s41423-020-00618-z","article-title":"Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy","volume":"18","author":"Mansilla","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.151905_bb0085","first-page":"1","article-title":"Advancing multiple sclerosis management in older adults","author":"van der Walt","year":"2025","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151905_bb0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12929-019-0609-7","article-title":"Clinical trials of new drugs for Alzheimer disease","volume":"27","author":"Huang","year":"2020","journal-title":"J. Biomed. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151905_bb0095","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","article-title":"ZINC: a free tool to discover chemistry for biology","volume":"52","author":"Irwin","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ijbiomac.2026.151905_bb0100","series-title":"910-1010 Sherbrooke St. W., Montreal, QC H3A 2R7","author":"M. Software","year":"2020"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151905_bb0105","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1021\/acschemneuro.1c00831","article-title":"Novel small-molecule inhibitor of NLRP3 Inflammasome reverses cognitive impairment in an Alzheimer\u2019s disease model","volume":"13","author":"Haseeb","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"7904","key":"10.1016\/j.ijbiomac.2026.151905_bb0110","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41586-022-04467-w","article-title":"Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3","volume":"604","author":"Hochheiser","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.151905_bb0115","series-title":"GROMACS 2024.2 Source code (2024.2)","author":"Abraham","year":"2024"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151905_bb0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field","volume":"12","author":"Lee","year":"2016","journal-title":"J. Chem. Theory Comput."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.151905_bb0125","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1016\/j.bmc.2016.06.034","article-title":"Parametrization of halogen bonds in the CHARMM general force field: improved treatment of ligand-protein interactions","volume":"24","author":"Soteras Gutierrez","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151905_bb0130","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151905_bb0140","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.ijbiomac.2026.151905_bb0145","series-title":"The Nose\u2013Hoover Thermostat, A'=(A Is) 1","first-page":"18","author":"Evans","year":"1985"},{"key":"10.1016\/j.ijbiomac.2026.151905_bb0150","doi-asserted-by":"crossref","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151905_bb0155","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2026.151905_bb0160","series-title":"The PyMOL Molecular Graphics System","year":"2025"},{"key":"10.1016\/j.ijbiomac.2026.151905_bb0165","series-title":"Discovery Studio Visualizer","year":"2024"},{"key":"10.1016\/j.ijbiomac.2026.151905_bb0170","series-title":"XMGrace","author":"Turner","year":"2005"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151905_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112265","article-title":"CARD-only proteins regulate in vivo inflammasome responses and ameliorate gout","volume":"42","author":"Devi","year":"2023","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151905_bb0180","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4049\/jimmunol.0900173","article-title":"Cutting edge: TNF-\u03b1 mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation","volume":"183","author":"Franchi","year":"2009","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151905_bb0185","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41573-023-00703-8","article-title":"Deuterium in drug discovery: progress, opportunities and challenges","volume":"22","author":"Di Martino","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6151","key":"10.1016\/j.ijbiomac.2026.151905_bb0190","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1126\/science.1240248","article-title":"Noncanonical inflammasome activation by intracellular LPS independent of TLR4","volume":"341","author":"Kayagaki","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151905_bb0195","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ni.1702","article-title":"An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome","volume":"10","author":"B\u00fcrckst\u00fcmmer","year":"2009","journal-title":"Nat. Immunol."},{"issue":"7237","key":"10.1016\/j.ijbiomac.2026.151905_bb0200","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151905_bb0205","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/brain\/awaa084","article-title":"NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients","volume":"143","author":"Malhotra","year":"2020","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151905_bb0210","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s12035-023-03618-y","article-title":"Inhibiting the NLRP3 Inflammasome with MCC950 alleviates neurological impairment in the brain of EAE mice","volume":"61","author":"Hou","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2026.151905_bb0215","series-title":"Surface plasmon resonance: methods and protocols","first-page":"15","article-title":"The role of mass transport limitation and surface heterogeneity in the biophysical characterization of macromolecular binding processes by SPR biosensing","author":"Schuck","year":"2010"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151905_bb0220","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1021\/acs.jmedchem.3c02098","article-title":"Discovery of potent, orally bioavailable, tricyclic NLRP3 inhibitors","volume":"67","author":"Velcicky","year":"2024","journal-title":"J. Med. Chem."},{"issue":"7944","key":"10.1016\/j.ijbiomac.2026.151905_bb0225","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41586-022-05570-8","article-title":"Cryo-EM structures of the active NLRP3 inflammasome disc","volume":"613","author":"Xiao","year":"2023","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151905_bb0230","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41582-020-0366-y","article-title":"NLRP3 inflammasome activity as biomarker for primary progressive multiple sclerosis","volume":"16","author":"Lempriere","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151905_bb0235","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-020-0145-7","article-title":"NLRP3 inflammasome as a novel therapeutic target for Alzheimer\u2019s disease","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151905_bb0240","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1189\/jlb.3A0415-155RR","article-title":"Sulforaphane inhibits multiple inflammasomes through an Nrf2-independent mechanism","volume":"99","author":"Greaney","year":"2016","journal-title":"J. Leukoc. Biol."},{"issue":"34","key":"10.1016\/j.ijbiomac.2026.151905_bb0245","doi-asserted-by":"crossref","first-page":"32008","DOI":"10.1074\/jbc.M104794200","article-title":"Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms","volume":"276","author":"Heiss","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151905_bb0250","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1359\/JBMR.040919","article-title":"Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity","volume":"19","author":"Yip","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151905_bb0255","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1042\/BJ20121651","article-title":"The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system","volume":"451","author":"Strickson","year":"2013","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151905_bb0260","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1124\/mol.106.023986","article-title":"Prevention of platelet glycoprotein IIb\/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor","volume":"70","author":"Wang","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151905_bb0265","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1021\/acs.jmedchem.6b01624","article-title":"Development of an acrylate derivative targeting the NLRP3 Inflammasome for the treatment of inflammatory bowel disease","volume":"60","author":"Cocco","year":"2017","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151905_bb0270","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.smim.2013.10.008","article-title":"Treating inflammation by blocking interleukin-1 in humans","volume":"25","author":"Dinarello","year":"2013","journal-title":"Semin. Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151905_bb0275","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2026.151905_bb0280","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","article-title":"Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-beta and cognitive function in APP\/PS1 mice","volume":"61","author":"Dempsey","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151905_bb0285","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1021\/acschembio.1c00218","article-title":"A probe for NLRP3 Inflammasome inhibitor MCC950 identifies carbonic anhydrase 2 as a novel target","volume":"16","author":"Kennedy","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2026.151905_bb0290","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajo.2023.05.007","article-title":"Risks of topical carbonic anhydrase inhibitors in glaucoma patients with chronic kidney disease: a nationwide population-based study","volume":"253","author":"Wang","year":"2023","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151905_bb0295","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1021\/acs.jmedchem.4c02759","article-title":"Discovery of DFV890, a potent sulfonimidamide-containing NLRP3 inflammasome inhibitor","volume":"68","author":"Shen","year":"2025","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.151905_bb0300","doi-asserted-by":"crossref","first-page":"14897","DOI":"10.1021\/acs.jmedchem.3c01398","article-title":"Discovery of clinical candidate NT-0796, a brain-penetrant and highly potent NLRP3 inflammasome inhibitor for neuroinflammatory disorders","volume":"66","author":"Harrison","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.151905_bb0305","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1182\/blood-2023-182210","article-title":"Modulation of NLRP3 Inflammasome in monocytes by HT-6184 in a single-cell proteomic study","volume":"142","author":"Bursey","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151905_bb0310","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s10020-024-00917-5","article-title":"Parthenolide ameliorates 3-nitropropionic acid-induced Huntington\u2019s disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting","volume":"30","author":"Noureldeen","year":"2024","journal-title":"Mol. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151905_bb0315","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.tips.2025.04.007","article-title":"Targeting the NLRP3 inflammasome for inflammatory disease therapy","volume":"46","author":"Cabral","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151905_bb0320","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s12035-023-03618-y","article-title":"Inhibiting the NLRP3 Inflammasome with MCC950 alleviates neurological impairment in the brain of EAE mice","volume":"61","author":"Hou","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2026.151905_bb0325","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbi.2023.11.031","article-title":"MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer\u2019s disease","volume":"116","author":"Naeem","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ijbiomac.2026.151905_bb0330","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/bs.apha.2024.10.004","article-title":"Biological and therapeutic significance of targeting NLRP3 inflammasome in the brain and the current efforts to develop brain-penetrant inhibitors","volume":"102","author":"Kaur","year":"2025","journal-title":"Adv. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151905_bb0335","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s44400-025-00011-5","article-title":"Post-symptomatic NLRP3 inhibition rescues cognitive impairment and mitigates amyloid and tau driven neurodegeneration","volume":"1","author":"Auger","year":"2025","journal-title":"NPJ Dement"},{"issue":"7434","key":"10.1016\/j.ijbiomac.2026.151905_bb0340","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151905_bb0345","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/s41467-024-45396-8","article-title":"Structural basis for the oligomerization-facilitated NLRP3 activation","volume":"15","author":"Yu","year":"2024","journal-title":"Nat. Commun."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026018313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026018313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:41:12Z","timestamp":1778719272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026018313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":68,"alternative-id":["S0141813026018313"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151905","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NIM5 series brain-penetrant NLRP3 inflammasome inhibitors suppress neuroinflammation in EAE and Alzheimer's models","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151905"}}